Allied Market Research


Exosome Research Products Market

Exosome Research Products Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product and Service, by Application and, by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Exosome research products market is expected to grow in the upcoming years. The factors driving the growth of the market are use of exosome - based processes and rise in investments made for research and development in the sector. Exosomes are extracellular lipid cysts that are very small measuring from 0nm to 120nm in diameter.


Exosomes are secreted by various types of cells. They are present in all body fluids including plasma, urine, serum and saliva. It consists of protein cargos and RNA. Exosomes are divided from different cell lines such as primary cultures, tumor line, virus infected cells. Increase in number of cancer patients has resulted in demand for exosomes research products market.

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID -19 is expected to have significant impact on Exosome Research Products Market.

Top Impacting factors:

  • The exosome research products market has been driven by factors such as increase in cancer patients around the world. Also, increase in investments for R&D purposes is boosting the exosome research products market growth.
  • Demand for personalized and customized medicine and increase in interest for exosome- based procedures is driving the growth of the exosome research products market.
  • Scarcity of trained and skilled professionals in exosome research sector and lack of awareness among the people are the factors affecting the growth of exosome research products market. Also, strict regulatory requirements for approval are hampering the growth of the market.

New Product Launch / News:

  • In May 2020, Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced  that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for its lead product, Organicell Flow, for patients diagnosed with moderate to severe acute respiratory syndrome (SARS) due to COVID-19 infection.
  • In 2018, Thermo Fisher Scientific extended its business in the U.S. by opening the Precision Medicine Science Center (PMSC) in Cambridge. This center produces analytical workflows to generate precise molecular profiles of patients.

Key benefits of the report:

  • This study presents the analytical depiction of the global exosome research products market along with the current trends and future estimations to determine the investments.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the exosome research products market share.
  • The current market is quantitatively analyzed to highlight the exosome research products market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed exosome research products market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the exosome research products market report: 

  • Which are the leading market players active in the exosome research products market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
  • What segments and regions will drive the market growth & why?
  • What are the new application areas of exosomes?

Exosome Research Products Market Report Highlights

Aspects Details
By Product and Service
  • Instruments
  • Services
  • Kits and Reagents
By Application
  • Cancer Applications
    • Breast Cancer
    • Prostate Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Other Cancers
  • Non cancer Applications
By End User
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinical Testing Laboratories
  • Academic and Research Institutes
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

Bio-Techne, System Biosciences, Thermo Fisher Scientific, Norgen Biotek Corp, NX Pharmagen, QIAGEN N.V, AMS Biotechnology, Lonza, Miltenyi Biotec

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Exosome Research Products Market

Global Opportunity Analysis and Industry Forecast, 2023-2032